Alyeska Investment Group
DARE icon

Alyeska Investment Group’s Dare Bioscience DARE Stock Holding History

Alyeska Investment Group’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,661
Closed -$677K – 472
2016
Q2 		$677K Buy
2,661
+54
+2% +$17.3K 0.01% 399
2016
Q1 		$848K Buy
2,607
+81
+3% +$22.8K 0.01% 358
2015
Q4 		$849K Buy
2,526
+155
+7% +$64.3K 0.01% 348
2015
Q3 		$1.04M Buy
2,371
+177
+8% +$89K 0.01% 384
2015
Q2 		$1.21M Buy
+2,194
New +$1.51M 0.01% 395

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group's DARE Position: Q3 2016 in Review

Alyeska Investment Group sold out of Dare Bioscience (DARE) in Q3 2016, closing a stake of 2,661 shares — an estimated $677K sold.

Alyeska Investment Group first reported a position in DARE in Q2 2015 and held it in 5 quarters. The position peaked at $1.21M in Q2 2015. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2016.

  • Alyeska Investment Group reported no remaining Dare Bioscience position as of Q3 2016 after selling out during the quarter.
  • Alyeska Investment Group sold 2,661 Dare Bioscience shares in Q3 2016, an estimated $677K.
  • Alyeska Investment Group first reported a position in Dare Bioscience in Q2 2015 and held it in 5 quarters.
  • Alyeska Investment Group's Dare Bioscience position peaked at $1.21M in Q2 2015.
  • 31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2016.

Based on Alyeska Investment Group's 13F filing for Q3 2016, filed 14 Nov 2016.